Structures by: Aatif A.
Total: 8
4-[(4-Allyl-2-methoxyphenoxy)methyl]-1-(4-methoxyphenyl)-1<i>H</i>-1,2,3-triazole
C20H21N3O3
Acta Crystallographica Section E (2020) 76, 6 962-966
a=16.212(3)Å b=5.9584(12)Å c=19.450(4)Å
α=90° β=110.537(3)° γ=90°
1,3-Bis[2-methoxy-4-(prop-2-en-1-yl)phenoxy]propane
C23H28O4
Acta Crystallographica Section E (2020) 76, 3 344-348
a=15.4741(5)Å b=5.0224(2)Å c=25.5180(9)Å
α=90° β=99.858(2)° γ=90°
C23H24N4O3
C23H24N4O3
Acta Crystallographica Section C (1999) 55, 2 IUC9900010
a=9.5570(10)Å b=16.1400(10)Å c=13.6880(10)Å
α=90.0000(10)° β=100.9780(10)° γ=90.0000(10)°
C23H26ClN4O3
C23H26ClN4O3
Acta Crystallographica Section C (1999) 55, 2 IUC9900010
a=9.9420(10)Å b=16.1840(10)Å c=13.7870(10)Å
α=90.0000(10)° β=107.6400(10)° γ=90.0000(10)°
C26H24N4O
C26H24N4O
Acta Crystallographica Section C (1999) 55, 9 1528-1530
a=8.8118(4)Å b=11.6060(6)Å c=12.1748(7)Å
α=115.234(2)° β=107.660(3)° γ=95.643(3)°
Rac-Ethyl 7-(4-chlorophenyl)-3a-methyl-3-(4-nitrophenyl)- 4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H- bis[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate
C39H32ClN7O4
Acta Crystallographica Section E (2007) 63, 4 o1544-o1545
a=17.3927(9)Å b=9.2018(5)Å c=22.8460(10)Å
α=90.00° β=107.102(5)° γ=90.00°
C33H38N4O2
C33H38N4O2
Acta Crystallographica Section C (2000) 56, 1 e25-e26
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C23H25N3O2
C23H25N3O2
Acta Crystallographica Section C (2000) 56, 10 e459-e460
a=14.4861(5)Å b=16.8720(10)Å c=17.9161(6)Å
α=90.000(10)° β=152.698(2)° γ=90.000(10)°